4
Changes in Ownership
Cabaletta Bio, Inc. Filed Acc 0000899243-23-017452
See Remarks sold 11,000 shares at an average $13.82 ($152,022)
- See Remarks acquired 11,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Binder Gwendolyn See Remarks | 2023-07-19 | Option exercise 10b5-1 | +11,000 | $1.01 | $11,110 | 31,000 | D |
| Binder Gwendolyn See Remarks | 2023-07-19 | Sale 10b5-1 | −8,185 | $13.67 | $111,879 | 22,815 | D |
| Binder Gwendolyn See Remarks | 2023-07-19 | Sale 10b5-1 | −2,815 | $14.26 | $40,143 | 20,000 | D |
| Derivatives | |||||||
| Binder Gwendolyn See Remarks | 2023-07-19 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,000 | 166,756 | D | ||
| Open-market sales · 11,000 sh · avg $13.82 · $152,022 | |||||||
Loading xslF345X05/doc4.xml…